IMC Chicago’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-22,406
| Closed | -$1.08M | – | 713 |
|
2025
Q1 | $1.08M | Buy |
+22,406
| New | +$1.08M | ﹤0.01% | 288 |
|
2024
Q4 | – | Sell |
-22,868
| Closed | -$1.46M | – | 737 |
|
2024
Q3 | $1.46M | Buy |
22,868
+11,019
| +93% | +$703K | ﹤0.01% | 183 |
|
2024
Q2 | $702K | Buy |
+11,849
| New | +$702K | ﹤0.01% | 402 |
|
2024
Q1 | – | Sell |
-42,674
| Closed | -$2.43M | – | 517 |
|
2023
Q4 | $2.43M | Buy |
+42,674
| New | +$2.43M | ﹤0.01% | 79 |
|
2023
Q3 | – | Sell |
-14,247
| Closed | -$741K | – | 332 |
|
2023
Q2 | $741K | Sell |
14,247
-29,997
| -68% | -$1.56M | ﹤0.01% | 112 |
|
2023
Q1 | $2.4M | Buy |
+44,244
| New | +$2.4M | ﹤0.01% | 33 |
|